These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30489674)

  • 1. Autonomic dysfunction in hereditary spastic paraplegia type 4.
    González-Salazar C; Takazaki KAG; Martinez ARM; Pimentel-Silva LR; Jacinto-Scudeiro LA; Nakagawa ÉY; Fujiwara Murakami CE; Saute JAM; Pedroso JL; Barsottini OGP; Teive HAG; França MC
    Eur J Neurol; 2019 Apr; 26(4):687-693. PubMed ID: 30489674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-motor symptoms in patients with hereditary spastic paraplegia caused by SPG4 mutations.
    Servelhere KR; Faber I; Saute JA; Moscovich M; D'Abreu A; Jardim LB; Teive HA; Lopes-Cendes I; Franca MC
    Eur J Neurol; 2016 Feb; 23(2):408-11. PubMed ID: 26806216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary spastic paraplegia SPG4: what is known and not known about the disease.
    Solowska JM; Baas PW
    Brain; 2015 Sep; 138(Pt 9):2471-84. PubMed ID: 26094131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of hereditary spastic paraplegia due to spastin mutation.
    McDermott CJ; Burness CE; Kirby J; Cox LE; Rao DG; Hewamadduma C; Sharrack B; Hadjivassiliou M; Chinnery PF; Dalton A; Shaw PJ;
    Neurology; 2006 Jul; 67(1):45-51. PubMed ID: 16832076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spastic paraplegia type 4: A novel SPAST splice site donor mutation and expansion of the phenotype variability.
    Kawarai T; Montecchiani C; Miyamoto R; Gaudiello F; Caltagirone C; Izumi Y; Kaji R; Orlacchio A
    J Neurol Sci; 2017 Sep; 380():92-97. PubMed ID: 28870597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel missense mutation in
    Wang XC; Liu RH; Wang T; Wang Y; Jiang Y; Chen DD; Wang XY; Hou TS; Kong QX
    Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36825575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neuropathy in hereditary spastic paraplegia due to spastin (SPG4) mutation--a neurophysiological study using excitability techniques.
    Kumar KR; Sue CM; Burke D; Ng K
    Clin Neurophysiol; 2012 Jul; 123(7):1454-9. PubMed ID: 22192498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation.
    Nielsen JE; Johnsen B; Koefoed P; Scheuer KH; Grønbech-Jensen M; Law I; Krabbe K; Nørremølle A; Eiberg H; Søndergård H; Dam M; Rehfeld JF; Krarup C; Paulson OB; Hasholt L; Sørensen SA
    Eur J Neurol; 2004 Dec; 11(12):817-24. PubMed ID: 15667412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary spastic paraplegia type 4 (SPG4): clinical and molecular-genetic characteristics].
    Rudenskaia GE; Sermiagina IG; Illarioshkin SN; Sidorova OP; Fedotov VP; Poliakov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):12-9. PubMed ID: 20559269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia.
    Sauter S; Miterski B; Klimpe S; Bönsch D; Schöls L; Visbeck A; Papke T; Hopf HC; Engel W; Deufel T; Epplen JT; Neesen J
    Hum Mutat; 2002 Aug; 20(2):127-32. PubMed ID: 12124993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticipation Can Be More Common in Hereditary Spastic Paraplegia with
    Hashemi SS; Hajati R; Davarzani A; Rohani M; DanaeeFard F; Rahimi Bidgoli MM; Fatehi F; Kariminejad A; Najmabadi H; Nafissi S; Alavi A
    Can J Neurol Sci; 2022 Sep; 49(5):651-661. PubMed ID: 34353391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4).
    Rattay TW; Boldt A; Völker M; Wiethoff S; Hengel H; Schüle R; Schöls L
    J Neurol; 2020 Feb; 267(2):369-379. PubMed ID: 31646384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic, structural and clinical analysis of spastic paraplegia 4.
    Varghaei P; Estiar MA; Ashtiani S; Veyron S; Mufti K; Leveille E; Yu E; Spiegelman D; Rioux MF; Yoon G; Tarnopolsky M; Boycott KM; Dupre N; Suchowersky O; Trempe JF; Rouleau GA; Gan-Or Z
    Parkinsonism Relat Disord; 2022 May; 98():62-69. PubMed ID: 35487127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia.
    Denton KR; Lei L; Grenier J; Rodionov V; Blackstone C; Li XJ
    Stem Cells; 2014 Feb; 32(2):414-23. PubMed ID: 24123785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of SPG4 and SPG3A genes and its implication in molecular diagnosis of Korean patients with hereditary spastic paraplegia.
    Park SY; Ki CS; Kim HJ; Kim JW; Sung DH; Kim BJ; Lee WY
    Arch Neurol; 2005 Jul; 62(7):1118-21. PubMed ID: 16009769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary spastic paraplegias.
    Lau KK; Ching CK; Mak CM; Chan YW
    Hong Kong Med J; 2009 Jun; 15(3):217-20. PubMed ID: 19494379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of patients with hereditary spastic paraplegia reveals seven novel mutations in the SPG4 (Spastin) gene.
    Proukakis C; Auer-Grumbach M; Wagner K; Wilkinson PA; Reid E; Patton MA; Warner TT; Crosby AH
    Hum Mutat; 2003 Feb; 21(2):170. PubMed ID: 12552568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Japanese SPG4 Patient with a Confirmed De Novo Mutation of the SPAST Gene.
    Nan H; Okamoto K; Gao L; Morishima Y; Ichinose Y; Koh K; Hashiyada M; Adachi N; Takiyama Y
    Intern Med; 2020 Sep; 59(18):2311-2315. PubMed ID: 32522921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight novel mutations in SPG4 in a large sample of patients with hereditary spastic paraplegia.
    Crippa F; Panzeri C; Martinuzzi A; Arnoldi A; Redaelli F; Tonelli A; Baschirotto C; Vazza G; Mostacciuolo ML; Daga A; Orso G; Profice P; Trabacca A; D'Angelo MG; Comi GP; Galbiati S; Lamperti C; Bonato S; Pandolfo M; Meola G; Musumeci O; Toscano A; Trevisan CP; Bresolin N; Bassi MT
    Arch Neurol; 2006 May; 63(5):750-5. PubMed ID: 16682546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal MRI-based study in patients with SPG4 mutations.
    Rezende TJ; de Albuquerque M; Lamas GM; Martinez AR; Campos BM; Casseb RF; Silva CB; Branco LM; D'Abreu A; Lopes-Cendes I; Cendes F; França MC
    PLoS One; 2015; 10(2):e0117666. PubMed ID: 25658484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.